Hulu for HealthcareJoin Today

Watch Todays Leading Researchers & Clinicians On-Demand

Treating With a JAK Inhibitor for Myelofibrosis

April 29th, 2019    29 Views

What is PD-1? Ask a Scientist

June 21st, 2016    2698 Views

BRCA Mutations

BRCA across tumour types

May 29th, 2018    1214 Views

Optimizing BRCA Testing in Advanced Ovarian Cancer

April 29th, 2019    103 Views

Pancreatic Cancer

Genetics in pancreatic cancer: Implications for clinical practice

August 13th, 2018    1151 Views

Genetics and Molecular Alterations in Pancreatic Cancer

July 30th, 2019    621 Views

BRAF Mutations

BRAF Mutations in Colorectal Cancer

September 6th, 2019    335 Views

Targeting BRAF in NSCLC

July 30th, 2019    69 Views

PD-L1 Mutations

Dr. Antonarakis on PD-1/PD-L1 Monotherapy in Prostate Cancer

March 27th, 2020    13 Views

How to intepret a PD-L1 immunostain

February 8th, 2019    2850 Views

TP53 Mutations

Metastatic Breast Cancer Forum 2018: HER2-positive Breast Cancer | Dana-Farber Cancer Institute

June 11th, 2019    1634 Views

TP53 and Deletion 17p as Prognostic Factors in CLL

March 30th, 2018    1469 Views

Recent Melanoma Research

About Mutations in Advanced (Unresectable or Metastatic) Melanoma

May 2nd, 2016    5041 Views

Rare mutation subgroups in melanoma and how to treat them

September 2nd, 2016    138 Views

PARP Inhibitors

Ask an Expert: How Do PARP Inhibitors Work?

March 27th, 2018    1304 Views

Clinical Data with PARP Inhibitors in Ovarian Cancer

June 27th, 2015    3503 Views

Antigen Retrieval in Immunohistochemistry

Better IHC Step 1: Antigen Retrieval

April 3rd, 2019    1648 Views

How to perform Antigen Retrieval (AR) in Immunohistochemistry (IHC) | CST Tech Tips

July 12th, 2018    4150 Views

ROS-1 Rearrangements in Lung Cancer

Dr. Riess on ROS1 Fusions in Lung Cancer

September 13th, 2016    315 Views

ROS1-Rearranged NSCLC

August 19th, 2019    143 Views

Understanding JAK Inhibition

Treating With a JAK Inhibitor for Myelofibrosis

April 29th, 2019    29 Views

Mechanism of Action of JAK Inhibitors

June 6th, 2017    34393 Views

ALK Inhibitors in Lung Cancer

Treating NSCLC Patients With a Next-Generation ALK TKI

September 16th, 2019    34 Views

Introduction to ALK inhibitors

June 17th, 2015    12390 Views

Acute Myeloid & Acute Lymphoblastic Leukemia

The evolving genomic landscape of ALL: molecular genetics, profiling and classification

March 2nd, 2018    100 Views

Acute Myeloid Leukemia - Diagnosis and Treatment in 2020

November 6th, 2019    2062 Views

Understanding FGFR Mutations

What is Fibroblast Growth Factor Receptor (FGFR)?

April 29th, 2014    4076 Views

Targeting FGFR in urothelial carcinoma

November 17th, 2019    99 Views

Circulating Tumor Cells

ESMO Expert video report on CTC and ctDNA in advanced NSCLC

April 24th, 2019    261 Views

Circulating tumor cells may identify asymptomatic late breast cancer recurrences

May 11th, 2018    264 Views

NTRK Fusions

NTRK Fusion Testing Across Cancers

September 17th, 2019    657 Views

ESMO Expert video report on Targeting NTRK gene fusions across cancers

May 13th, 2019    514 Views

Inspiring Discussions on Cytogenetics

IPPCR: Developing Protocols and Manuals of Operating Procedures

March 12th, 2020    4204 Views

Is the Study of Monogenic Diseases of the Immune System Relevant?

March 8th, 2020    575 Views

Featured Videos from Sponsors

FISH Probe Optimization

February 19th, 2020    539 Views

FFPE Slide Optimization Tips & Tricks

February 28th, 2020    289 Views